Prime Editing Makes Therapeutic T Cells Controllable Under Immunosuppression
Investigators developed a multiplex prime-editing framework that combines correction of pathogenic T-cell mutations with engineered resistance to commonly used immunosuppressive drugs. Corrected T cells from patients with subcutaneous panniculitis-like T-cell lymphoma selectively expanded under…
